Berry boost: blueberries protect dopamine cells

Researchers report that adding blueberries to the diet reduced brain injury and movement problems in a laboratory model of Parkinson’s disease, suggesting the fruit’s anti-inflammatory and antioxidant compounds could be protective. In the new study researchers fed animals a diet containing 6 percent freeze-dried blueberries and then tested them in a common Parkinson’s model. Compared with animals on a regular diet, the blueberry group showed smaller motor deficits, less loss of dopamine-producing neurons in the brain region linked to Parkinson’s, and lower activation of microglia, the brain’s immune cells. In plain terms, the animals moved better and their brains looked less damaged after the toxic insult used to mimic Parkinson’s. Why might blueberries help? Blueberries are rich in anthocyanins and other polyphenols — plant chemicals that reduce oxidative stress and calm inflammation. Those two processes are strongly implicated in the neuronal damage seen in Parkinson’s. Lab work dating back many years has shown similar protective effects of berry compounds on brain cells and behaviour, so the new paper adds to a growing body of preclinical evidence that blueberries can support brain health. Important caveats. This was an animal study using a toxin to model Parkinson’s-like damage. Animal results do not automatically translate to humans. Dose matters: the amount and form of blueberry used in labs is not the same as eating a punnet each day, and the way the compounds are delivered and absorbed can differ between species. Clinical trials in people are needed before anyone can claim that blueberries prevent or slow Parkinson’s. What this means for you today is straightforward and practical. Eating blueberries as part of a varied, plant-rich diet is sensible and safe for most people and may offer general benefits for heart and brain health. However, they are not a treatment for Parkinson’s and should not replace medical care or approved therapies. Researchers now have another encouraging lead to follow up with further studies, ideally including human trials that examine whether similar benefits appear in people.